Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
51.50
+1.24 (2.47%)
Aug 15, 2025, 3:44 PM EDT
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
$626,493
Profits / Employee
$223,068
Market Cap
227.24B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
Silence Therapeutics | 116 |
Novo Nordisk News
- 13 hours ago - Novo Nordisk's Wegovy gets accelerated US FDA approval for liver disease MASH - Reuters
- 13 hours ago - Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH - GlobeNewsWire
- 13 hours ago - Why Novo Nordisk Flew Almost 3% Higher on Friday - The Motley Fool
- 13 hours ago - NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit - PRNewsWire
- 16 hours ago - Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst - Benzinga
- 16 hours ago - Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst - Benzinga
- 17 hours ago - DEADLINE ALERT for FLYW, LMT, SOC, NVO: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewsWire
- 18 hours ago - Novo Nordisk Stock Could Benefit From Eli Lilly's Weight-Loss Price Hikes - Barrons